黄培钰 - 中山大学 - 肿瘤防治中心

个人简介

主要学历：　1995.9 -2002.7 中山医科大学临床医学七年制本硕连读。　2005.9 -2009.7 中山大学肿瘤防治中心鼻咽癌科博士研究生。工作经历：　2002年起从事鼻咽癌的临床诊治工作。治疗鼻咽癌患者2千余例。对鼻咽癌综合治疗，特别是化放疗及免疫、分子靶向治疗有较丰富的临床经验。具有丰富的教学经验，被评为2013年中山大学优秀临床带教老师。　2002年起历任中山大学肿瘤防治中心鼻咽癌科住院医师、主治医师、副主任医师。　2016年于美国排名第一的MD Anderson 癌症中心访学1年。　2019年起任中山大学肿瘤防治中心鼻咽癌科主任医师

研究领域

鼻咽癌的化、放综合治疗及免疫、分子靶向治疗研究。

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1.Huang PY, Zeng Q, Cao KJ, Guo X, Guo L, Mo HY, Wu PH, Qian CN, Mai HQ, Hong MH. Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area.Eur J Cancer. 2015 Sep;51(13):1760-70. (IF 7.191) 2. Huang PY, Wang CT, Cao KJ, Guo X, Guo L, Mo HY, Wen BX, Wu YS, Mai HQ, Hong MH *. Pretreatment body mass index as an independent prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy: Findings from a randomised trial. Eur J Cancer. 2013 May;49(8):1923-31. (IF 7.191) 3. Peng PJ, Lv BJ, Wang ZH, Liao H, Liu YM, Lin Z, Con YY, Huang PY(Corresponding author). Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens. Ther Adv Med Oncol. 2017 Feb;9(2):68-74. (IF 6.238 ) 4. Wu,X, Huang PY (Co-first author), Peng, PJ，Han F, Zhao C, Zhang L*. Long term follow up of a PhaseIII Study Comparing Radiotherapy with or without Weekly Oxaliplatin for Locoregionally Advanced Nasopharyngeal Carcinoma. Ann Oncol. 2013 Aug;24(8):2131-6. (IF 13.926) 5. Xue C, Huang Y, Huang PY (Co-first author), Yu QT, Pan JJ, Liu LZ, Song XQ, Lin SJ, Wu JX, Zhang JW, Zhao HY, Xu F, Liu JL, Hu ZH, Zhao LP, Zhao YY, Wu X, Zhang J, Ma YX, Zhang L*. Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma. Ann Oncol. 2013 Apr;24(4):1055-61. (IF 13.926) 6.You R, Cao YS, Huang PY(Co-first author), Chen L, Yang Q, Liu YP, Zou X, Zhang YN, Jiang R, Zhang MX, Duan CY, Lin AH, Hong MH, Chen MY. The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis. Theranostics. 2017 Oct 17;7(19):4825-4835. (IF 8.537) 7. Zhang L, MacIsaac KD, Zhou T, Huang PY(Co-first author), Xin C, Dobson JR, Yu K, Chiang DY, Fan Y, Pelletier M, Wang Y, Jaeger S, Krishnamurthy Radhakrishnan V, JeBailey L, Skewes-Cox P, Zhang J, Fang W, Huang Y, Zhao H, Zhao Y, Li E, Peng B, Huang A, Dranoff G, Hammerman PS, Engelman J, Bitter H, Zeng YX, Yao Y. Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes.Mol Cancer Res. 2017 Dec;15(12):1722-1732. (IF 4.597 )